bioRxivNeurosciencePreprint
Csf1r-mediated depletion of midbrain microglia prevents dopaminergic neuron loss during chronic colitis
Rebecca Katharina MasanetziD, Iris Stolzer, Emely Elisa Neumaier, Mark Dedden, Pavel KielkowskiiD, Wei Xiang, Alexander GrotemeyeriD, Marco PrinziD, Takahiro MasudaiD, Klaus‐Peter KnobelochiD, Veit RothhammeriD, Sebastian ZundleriD, Johannes C. M. SchlachetzkiiD, Jürgen WinkleriD, Claudia GüntheriD, Patrick SüßiD
Abstract
Inflammatory bowel disease (IBD) predisposes to neuropsychiatric comorbidity and particularly increases the risk of Parkinsons Disease (PD) in later life. Although the gut-immune-brain axis was proposed as a link between IBD and PD and a driver of PD immunopathogenesis, the regional pattern and single-cell landscape of the brain immune response during colitis and its contribution to PD pathology remain poorly defined. Here, we observe a loss of dopaminergic neurons in the substantia nigra pars compacta of adult mice with chronic colitis. By confocal microscopy and integrated multi-omics, we reveal a complex midbrain-centered immune response to chronic colitis in comparison to the cortex, hippocampus, and striatum. Single-cell mapping of the midbrain immune landscape showed an inflammatory shift of microglial clusters including an expansion of interferon-response microglia, CD8+ T cell extravasation, and increased numbers of vessel-associated neutrophils. Selective myeloid cell depletion using a colony stimulating factor 1 receptor (Csf1r) inhibitor after colitis onset reduced midbrain microglia by 67% and led to a complete rescue of dopaminergic neuron loss, without affecting mucosal pathology or T cell and neutrophil migration to the midbrain. Collectively, within the complex innate and adaptive midbrain immune response to chronic colitis, we demonstrate a causal role of Csf1r-dependent microglia for dopaminergic neurodegeneration. Thus, Csf1r inhibition in IBD may not locally ameliorate colitis, but provide neuroprotection to dopaminergic neurons. These results reveal a novel cellular link between chronic gut-derived peripheral inflammation and midbrain vulnerability and thereby substantially enhance our understanding of the risk for PD related to the gut-immune-brain axis. O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=174 SRC="FIGDIR/small/700559v1_ufig1.gif" ALT="Figure 1"> View larger version (58K): org.highwire.dtl.DTLVardef@1bf7217org.highwire.dtl.DTLVardef@1db66c0org.highwire.dtl.DTLVardef@136ef2eorg.highwire.dtl.DTLVardef@190f641_HPS_FORMAT_FIGEXP M_FIG Graphical abstract. C_FIG
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Locus coeruleus injury modulates ventral midbrain neuroinflammation during DSS-induced colitis
Jake Sondag Boles, Jenny Holt, … Malú G. Tansey·bioRxiv·Feb 12, 2024
- Intragastric administration of low-dose rotenone post-colitis exacerbates damage to the nigrostriatal dopaminergic system in Parkinson's disease: The pace accelerates even more
Nishant Sharma, Monika Sharma, … Amit Khairnar·bioRxiv·Dec 22, 2022
- DSS-induced inflammation in the colon drives a pro-inflammatory signature in the brain that is ameliorated by prophylactic treatment with the S100A9 inhibitor paquinimod
S. Talley, R. Valiauga, … E. M. Campbell·bioRxiv·Sep 22, 2021
- RORγt-Expressing Pathogenic CD4+T Cells Cause Brain Inflammation During Chronic Colitis
R. Basu, M. E. Mickael, … D. G. Standaert·bioRxiv·Sep 1, 2021
- Experimental colitis drives enteric alpha-synuclein accumulation and Parkinson-like brain pathology
Stefan A. Grathwohl, Quansah, Emmanuel, … Markus Britschgi·Free NeuropathologyPeer-reviewed·Apr 7, 2021
- A single Citrobacter rodentium infection in Pink1 knockout and wild type mice leads to regional blood-brain-barrier perturbation and limited microglial activation without dopamine neuron axon terminal loss
Sriparna Mukherjee, Vladimir Grouza, … Louis‐Éric Trudeau·bioRxiv·Dec 24, 2024